Integral dose delivered to normal brain with conventional intensity-modulated radiotherapy (IMRT) and helical tomotherapy IMRT during partial brain radiotherapy for high-grade gliomas with and without selective sparing of the hippocampus, limbic circuit and neural stem cell compartment

Journal of Medical Imaging and Radiation Oncology

Volumn 57, Issue 3, 2013, Pages 378-383

  Marsh, James C ^a   Ziel, G Ellis ^c   Diaz, Aidnag Z ^c   Wendt, Julie A ^b   Gobole, Rohit ^d   Turian, Julius V ^c  

^a 21ST CENTURY ONCOLOGY   (United States)

^b Allergy Asthma and Immunology Associates of Arizona ^*  (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d RUSH MEDICAL COLLEGE   (United States)

Author keywords

glioma; integral dose; radiation oncology; radiotherapy; tomotherapy

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CELL COMPARTMENTALIZATION; DOSIMETRY; GLIOMA; HIPPOCAMPUS; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LIMBIC CORTEX; NEURAL STEM CELL; PRIORITY JOURNAL; RADIATION DOSE; TOMOTHERAPY;

ADULT; BODY BURDEN; BRAIN NEOPLASMS; GLIOMA; HIPPOCAMPUS; HUMANS; MALE; NEURAL STEM CELLS; ORGAN SPARING TREATMENTS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; TREATMENT OUTCOME;

EID: 84878603454     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/1754-9485.12048     Document Type: Article

References (35)

1. Chan MD, Tatter SB, Lesser G, Shaw EG,. Radiation oncology in brain tumors: current approaches and clinical trials in progress. Neuroimaging Clin N Am 2010; 20: 401-408.
2. Kortmann RD, Timmermann B, Taylor RE, et al. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part I: treatment modalities of radiation therapy. Strahlenther Onkol 2003; 179: 509-520.
3. Finlay JL, Zacharoulis S,. The treatment of high grade gliomas and diffuse intrinsic pontine tumors of childhood and adolescence: a historical-and futuristic-perspective. J Neurooncol 2005; 75: 253-266.
4. Bauman GS, Gaspar LE, Fisher BJ, Halperin EC, Macdonald DR, Cairncross JG,. A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1994; 29: 835-839.
5. Roman DD, Sperduto PW,. Neuropsychological effects of cranial radiation: current knowledge and future directions. Int J Radiat Oncol Biol Phys 1995; 31: 983-998.
6. Nandagopal R, Laverdiere C, Mulrooney D, Hudson MM, Meacham L,. Endocrine late effects of childhood cancer therapy: a report from the Children's Oncology Group. Horm Res 2008; 69: 65-74.
7. Merchant TE, Kiehna EN, Li C, et al. Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma. Int J Radiat Oncol Biol Phys 2006; 65: 210-221.
8. Kortmann RD, Timmermann B, Taylor RE, et al. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: treatment-related late toxicity. Strahlenther Onkol 2003; 179: 585-597.
9. Bitzer M, Topka H,. Progressive cerebral occlusive disease after radiation therapy. Stroke 1995; 26: 131-136.
10. Marks JE, Baglan RJ, Prassad SC, Blank WF,. Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation, and volume. Int J Radiat Oncol Biol Phys 1981; 7: 243-252.
11. Hall EJ, Wuu CS,. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003; 56: 83-88.
12. Ruben JD, Davis S, Evans C, et al. The effect of intensity-modulated radiotherapy on radiation-induced second malignancies. Int J Radiat Oncol Biol Phys 2008; 70: 1530-1536.
13. Zach L, Stall B, Ning H, et al. A dosimetric comparison of four different treatment planning methods for high grade glioma. Radiat Oncol 2009; 4: 45.
14. Shi C, Penagaricano J, Papanikolaou N,. Comparison of IMRT treatment plans between linac and helical tomotherapy based on integral dose and inhomogeneity index. Med Dosim 2008; 33: 215-221.
15. Raggi E, Mosleh-Shirazi MA, Saran FH,. An evaluation of conformal and intensity-modulated radiotherapy in whole ventricular radiotherapy for localized primary intracranial germinomas. Clin Oncol (R Coll Radiol) 2008; 20: 253-260.
16. Chen MJ, Santos Ada S, Sakuraba RK, et al. Intensity-modulated and 3D-conformal radiotherapy for whole-ventricular irradiation as compared with conventional whole-brain irradiation in the management of localized central nervous system germ cell tumors. Int J Radiat Oncol Biol Phys 2010; 76: 608-614.
17. MacDonald SM, Ahmad S, Kachris S, et al. Intensity modulated radiation therapy versus three-dimensional conformal radiation therapy for the treatment of high grade glioma: a dosimetric comparison. J Appl Clin Med Phys 2007; 8: 47-60.
18. Marsh JC, Godbole R, Diaz AZ, Gielda BT, Turian JV,. Sparing of the hippocampus, limbic circuit, and neural stem cell compartment during partial brain radiotherapy for glioma: a dosimetric feasibility study. J Med Imaging Radiat Oncol 2011; 55: 442-449.
19. Chera BS, Amdur RJ, Patel P, Mendenhall MW,. A radiation oncologist's guide to contouring the hippocampus. Am J Clin Oncol 2009; 32: 20-22.
20. Armstrong GT,. Long-term experience of childhood central nervous system malignancies: the experience of the Childhood Cancer Survivor Study. Eur J Paediatr Neurol 2010; 14: 298-303.
21. Walter AW, Hancock ML, Pui CH, et al. Secondary brain tumors in children treated for acute lymphoblastic leukemia at St. Jude Children's Hospital. J Clin Oncol 1998; 16: 3761-3767.
22. Relling MV, Rubnitz JE, Rivera GK, et al. High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet 1999; 354: 34-39.
23. Palma L, Vagnozzi R, Annino L, Ciapetta P, Maleci A, Cantore G,. Post-radiation glioma in a child. Case report and review of the literature. Childs Nerv Syst 1988; 4: 296-301.
24. Shapiro S, Mealey J Jr,. Late anaplastic gliomas in children previously treated for acute lymphoblastic leukemia. Pediatr Neurosci 1989; 15: 176-180.
25. Prasad G, Haas-Kogan DA,. Radiation-induced gliomas. Expert Rev Neurother 2009; 9: 1511-1517.
26. Mulhern RK, Palmer SL, Reddick WE, et al. Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. J Clin Oncol 2001; 19: 472-479.
27. Gutierrez AN, Westerly DC, Tome WA, et al. Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning study. Int J Radiat Oncol Biol Phys 2007; 69: 589-597.
28. Gondi V, Tolakanahalli R, Mehta MP, et al. Hippocampal-sparing whole-brain radiotherapy: a 'how-to' technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2010; 78: 1244-1252.
29. Gondi V, Tome WA, Mehta MP,. Why avoid the hippocampus? A comprehensive review. Radiother Oncol 2010; 97: 370-376.
30. Marsh J, Gielda B, Herskovic A, Wendt J, Turian J,. Sparing of the hippocampus and limbic circuit during whole brain radiation therapy. J Med Imaging Radiat Oncol 2010; 54: 375-382.
31. Cho KH, Kim JY, Lee SH, et al. Simultaneous integrated boost intensity-modulated radiotherapy in patients with high-grade gliomas. Int J Radiat Oncol Biol Phys 2010; 78: 390-397.
32. Boehling NS, Grosshans DR, Bluett JB, et al. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngioma. Int J Radiat Oncol Biol Phys 2011; 82: 643-652.
33. Athar BS, Bednarz B, Seco J, Hancox C, Paganetti H,. Comparison of out-of-field photon doses in 6 MV IMRT and neutron doses in proton therapy for adult and pediatric patients. Phys Med Biol 2010; 55: 2879-2891.
34. Zacharatou Jarlskog C, Paganetti H,. Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age. Int J Radiat Oncol Bioll Phys 2008; 72: 228-235.
35. Hall EJ,. Intensity-modulated radiation therapy, protons, and the risks of second cancers. Int J Radiat Oncol Biol Phys 2006; 65: 1-7.